Morishige K, Shimokawa H, Eto Y, Kandabashi T, Miyata K, Matsumoto Y, Hoshijima M, Kaibuchi K, Takeshita A
Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):548-54. doi: 10.1161/01.atv.21.4.548.
Small GTPase Rho and its target Rho-kinase/ROK/ROCK play an important role in various cellular functions, including smooth muscle contraction, actin cytoskeleton organization, and cell adhesion and migration, all of which may be involved in the pathogenesis of arteriosclerosis. Here, we show that adenovirus-mediated transfer of dominant-negative Rho-kinase (DNRhoK) induces a marked regression of coronary constrictive remodeling and abolishes coronary vasospastic activity in vivo. Porcine coronary segments were chronically treated with interleukin-1beta, which resulted in the development of constrictive remodeling and vasospastic responses to serotonin, as previously reported. Adenovirus-mediated transfer of DNRhoK, but not that of beta-galactosidase, into the interleukin-1beta-treated coronary segment caused a marked regression of the constrictive remodeling and abolished the vasospastic activity in 3 weeks. Western blot analysis showed that the phosphorylation of adducin and the ezrin/radixin/moesin family, the target proteins of Rho-kinase, were upregulated at the coronary lesions and were significantly suppressed by the transfer of DNRHOK: These results indicate that Rho-kinase is substantially involved in coronary constrictive remodeling and vasospastic responses, both of which can be reversed by the selective inhibition of the molecule in our porcine model in vivo.
小GTP酶Rho及其靶标Rho激酶/ROK/ROCK在多种细胞功能中发挥重要作用,包括平滑肌收缩、肌动蛋白细胞骨架组织以及细胞黏附和迁移,所有这些功能都可能参与动脉粥样硬化的发病机制。在此,我们表明腺病毒介导的显性负性Rho激酶(DNRhoK)的转导可诱导冠状动脉狭窄性重塑显著消退,并在体内消除冠状动脉痉挛活性。如先前报道,用白细胞介素-1β对猪冠状动脉节段进行长期处理,会导致狭窄性重塑的发展以及对5-羟色胺的血管痉挛反应。腺病毒介导的将DNRhoK而非β-半乳糖苷酶转导至经白细胞介素-1β处理的冠状动脉节段,在3周内可导致狭窄性重塑显著消退并消除血管痉挛活性。蛋白质印迹分析表明,Rho激酶的靶蛋白内收蛋白和埃兹蛋白/根蛋白/膜突蛋白家族的磷酸化在冠状动脉病变处上调,并通过转导DNRHOK而被显著抑制:这些结果表明,Rho激酶在冠状动脉狭窄性重塑和血管痉挛反应中起重要作用,在我们的猪体内模型中,通过对该分子的选择性抑制,这两种反应均可被逆转。